Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system

Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration ... https://t.co/wCOWIRzfTO

#JITC Research: Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system https://t.co/KyILPtBztZ https://t.co/f7A5acA52C

RT @jitcancer: New #JITC Research: Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Admin…

New #JITC Research: Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system https://t.co/KyILPtBztZ https://t.co/m9wqylMLTk

Retrospective pharmacovigilance analysis of 29,294,336 records in the US FDA Adverse Events Reporting System database showed a high reporting frequency of endocrine adverse events from mono- and combination #immunotherapy: https://t.co/DmC2AAxmx5 @jitcance